AMY DOOLEY-SPEEGLE: Open Payments
NPI 1134466618 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,304 in 142 payments from 14 companies in 2025. Trend: 2023 $1,258 · 2024 $1,839 · 2025 $3,304
Food & beverage: $3,205Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $1,124 |
| Janssen Biotech, Inc. | 18 | $589 |
| Phathom Pharmaceuticals, Inc. | 12 | $301 |
| Madrigal Pharmaceuticals | 10 | $236 |
| Aimmune Therapeutics, Inc. | 8 | $222 |
| Gilead Sciences, Inc. | 5 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $172 |
| Lilly USA, LLC | 9 | $157 |
| Ardelyx, Inc. | 6 | $118 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
Products named: TREMFYA, RINVOQ, VOQUEZNA, SKYRIZI, REZDIFFRA, ZENPEP, ENTYVIO, MAVYRET.
Industry payments across AL — which companies pay providers there.
